O&
Organon & Co
🇩🇪XFRA.7XPGermanyHealthcare
€11.91EURup +0.08 (+0.68%)OpenEnd of day7:42 AM
Price€11.91+0.08 (+0.68%)
Profile
- Healthcare
- Drug Manufacturers - General
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US68622V1061
- CUSIP
- Not reported
Company
- Employees
- 10,000
- Headquarters
- Jersey City, United States
- Website
- https://www.organon.com
- CEO
- Mr. Joseph T. Morrissey Jr.
Market
- Shares outstanding
- 260M
- Market cap
- €3.1B
Key dates
- Next earnings
- Nov 9, 2026
Highlights
- Market cap
- €3.1B
- EPS LTM
- $0.77
- P/E LTM
- 17.47
- Div yield
- 0.49%
Fundamentals (LTM)
- Revenue
- $6.13B-2.45%down year on year
- Net income
- $209M-70.14%down year on year
- Gross margin
- 52.98%-5.84%down year on year
- Free cash flow
- $498M+3.32%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.